Accumulating evidence indicates that survivin is frequently overexpressed in human cancers, including non-small cell lung cancer10, prostate cancer11, colorectal cancer12, gastric cancer13, and hepatocellular carcinoma14. The gene discussed is BIRC5; the disease is cancer.